An interventional study of 8 week predominantly plant-based New Nordic LPF-diet program and maintenance of the predominantly plant-based New Nordic LPF-diet in Parkinson Disease, sponsored by University of Kiel. Not yet recruiting at 2 sites in Germany. Open to participants aged 50 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-04-29.
Sponsored by University of Kiel · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 264 studies in Parkinson Disease with a site in Germany — 41 open to participants now, 53 under way, 2 of them phase 3. Parkinson Disease · Germany.
Among the 264 studies in Parkinson Disease with a site in Germany, this one is the 119th largest by planned enrollment of the 198 interventional ones that give a count, is one of 8 that started in 2026, is one of 50 with no phase, reaches primary completion later than 31 of the 52 other live ones, and was the 233rd registered.
4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.
Browse Parkinson Disease studies →41 of the 264 studies in Parkinson Disease with a site in Germany are open now. Recruiting first, the newest first:
University Hospital Tuebingen · Sites in Germany, France, Italy and 4 more countries
Ages 35–80
MODAG GmbH · Sites in Germany
Ages 50–75 · Healthy volunteers
H. Lundbeck A/S · Sites in Germany, United States, Czechia and 1 more country
Ages 40–85
University Hospital Muenster · Sites in Germany
Ages 18+
Integrative Research Laboratories AB · Sites in Germany, Bulgaria, Poland and 1 more country
Ages 50–90
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.
This study: 50 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
264 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 16 · Phase 2 53 · Phase 3 65 · Phase 4 19
First in 2001; this study’s year is marked. 8 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 75 is above the median of 40 across 3,360 interventional studies indexed under Parkinson Disease.
Median enrollment 106 across the 198 interventional studies, 195 across the 64 observational. Of the 186 that completed or were terminated, 73 (39%) have results posted.
This tab as a report to print or save as PDF → With an account.
173 of 264 have an industry lead sponsor. The 10 most frequent:
University of Kiel is the lead sponsor of 26 studies on the registry; 7 are open to participants now.
University of Kiel has 6 studies filed under Parkinson Disease — fewer than ten, so there is no comparison to draw.
15 of the studies in Parkinson Disease with a site in Germany that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07134634Parkinson's Clinic in Beelitz-HeilstattenEffect of a Vibrating Therapy Ball on Tremor and Daily Activities in Patients With Different Tremor Syndroms | 2026-11 |
| NCT06580977Heidelberg UniversityExploring the Effects of Exercise on Memory and Cognition in Parkinson´s Disease | 2026-12 |
| NCT07141719University of KielCollection of Digital Parameters From Parts of the Neurological Examination Using an Eye Tracker | 2026-12-31 |
| NCT06602193Denali Therapeutics Inc.Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD) | 2027-03 |
| NCT06993571Universitätsklinikum Hamburg-EppendorfCerebellar Transcranial Alternating Current Stimulation (tACS) to Modulate Parkinson's Disease Tremor | 2027-03-31 |
Add all 15 to your calendar (.ics) → With an account.
Among the 264 studies in Parkinson Disease with a site in Germany, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Habitual adherence to a predominantly plant-based diet, rich in low-processed food (LPF) has been associated with a reduced risk for development and slower progression of Parkinson's Disease (PD). This could be due to neuroprotective effects by modulation of the gut microbiota and decreased neuronal and metabolic inflammation. So far, the effect of a predominantly plant-based LPF-diet on the microbiome-immune-brain axis in patients with PD remains unknown. In addition, the influence of dietetic measures on the gut microbiome is variable and may depend on (long-term) adherence as well as on PD-specific factors and lifestyle.
The investigators hypothesize that compared to an average German diet, the predominantly plant-based New Nordic LPF-diet, as a culturally adapted diet, which is rich in fermentable fiber and phytochemicals, will have beneficial effects on the gut microbiome of patients with PD by increasing the abundance of short-chain fatty acid (SCFA)-producing bacteria (primary outcome) and will improve gut motility, metabolic resilience, and inflammation (secondary outcomes). Furthermore, the investigators postulate that a patient-centered dietary intervention program, including a multifaceted patient education and supported by a web-application, will lead to high adherence as a key determinant of long-term changes in the gut microbiome. This dietary intervention will be accepted by patients as a low-threshold treatment that balances personal benefits, therapeutic barriers and ethical concerns of early risk disclosure in PD.
In a pilot-intervention study, our project will:
The patient-centered intervention program will be tailored to individual needs and preferences of individuals with prodromal and clinical PD. It will be designed to impart knowledge (e.g. on sustainability and health effects) and food literacy (e.g. food merchandize and culinary skills) in group meetings and culinary medicine workshops. Recipe suggestions and shopping guides will consider individual abilities and needs and a web-application is used for information, increasing self-efficacy, motivation, and monitoring. To ensure an easy integration of the diet into everyday life, partners will be included in the program, if applicable. Moreover, cultural preferences as well as financial resources will be considered. Regular feedback using statistics on nutrient intake and overall progress will be implemented to encourage adherence.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients with prodromal PD will take part in an 8-week patient-centered intervention program on a predominantly plant-based New Nordic LPF-Diet.
Behavioral: 8 week predominantly plant-based New Nordic LPF-diet program · Behavioral: maintenance of the predominantly plant-based New Nordic LPF-diet
Patients with clinical PD will take part in an 8-week patient-centered intervention program on a predominantly plant-based New Nordic LPF-Diet. Patients with clinical PD will be randomized to intervention or control group.
Behavioral: 8 week predominantly plant-based New Nordic LPF-diet program · Behavioral: maintenance of the predominantly plant-based New Nordic LPF-diet
Patients with clinical PD will receive standard of care information on a healthy diet and serve as control. Patients with clinical PD will be randomized to intervention or control group.
An 8-week patient-centered dietary intervention program will be implemented to maintain a predominantly plant-based New Nordic LPF-Diet.
Follow-up of long-term adherence to the diet at one and six months after completion of the intervention program.
abundance of key SCFA-producing gut bacteria
analysis of stool samples
Time frame: pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
systemic inflammation markers
hsCRP and IL-6 in serum
Time frame: pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
metabolic resilience
modeling of one parameter (metabolic resilience) including information on postprandial glucose, insulin, triglycerides and NEFA following a mixed meal tolerance test
Time frame: pre vs. post intervention (8 weeks)
gastrointestinal peptide-hormones
ghrelin, GLP-1, PYY
Time frame: pre vs. post intervention (8 weeks)
energy balance
changes in body weight
Time frame: pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
energy partitioning
changes in body composition
Time frame: pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
clinical motor symptoms
clinical examination
Time frame: pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
clinical non-motor symptoms
clinical examination
Time frame: pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
gastric emptying
13C-breath test
Time frame: pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
gastrointestinal transit time
using a test meal with food colouring and the time to colour appearance in stool
Time frame: pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
gut motility
functional visceral MRI
Time frame: pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
dietary adherence via serum markers
serum carotinoid and Trimethylamine oxid-levels will be combined and tertiles will be formed
Time frame: pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
dietary adherence via healthy Nordic food Index
healthy Nordic food Index using data from a food frequency questionnaire
Time frame: pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
food literacy effectiveness
self-perceived food literacy scale (questionnaire)
Time frame: pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
patient acceptance
Parkinson's Disease Questionnaire (PDQ-39)
Time frame: pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
patient quality of life
Ways of Coping Questionnaire (WCQ)
Time frame: pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
Plan to share: No
Start is estimated for May 2026; primary completion for Dec 2027, 19 months later.
Of 1,297 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 19 months is below that.
Counting every sponsor, half of 1,373 studies reached it within 25 months; a quarter within 11 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Kiel